|
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of hundreds of brand-name antibiotics, heart drugs, heartburn medications, and more. Teva's US generic products include equivalents of such blockbusters as antidepressant Prozac and osteoporosis drug Fosamax. The company, Israel's top drug maker, also develops and manufactures proprietary drugs, including multiple sclerosis treatment Copaxone, Parkinson's disease treatment Azilect, and a portfolio of women's health treatments. Its active pharmaceutical ingredients division makes drug components for Teva and other manufacturers.
|
| | | Contact Information | |
Address: |
5 Basel St
Petah Tikva 49131, Israel
| | Phone: | +972-3-926-7267 | | Fax: | +972-3-923-4050 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 11085.00 M | | Revenue Growth (1 yr): | 17.80% | | Employees (2008): | 38,307 | | Employee Growth (1 yr): | 37.20% |
|
|
Key People
| | • |
Chairman:
Eli Hurvitz
| | • |
President and CEO:
Shlomo Yanai
| | • |
CFO:
Eyal Desheh
|
|
|
